在工程化大肠杆菌中进行高效性赤素合成的代谢控制
Zheng Lei1,2, Xiangsong Chen2, Lixia Yuan2
1University of Science and Technology of China, Hefei 230026, China.
ACS synthetic biology
|July 15, 2025
概括
这项研究使大肠杆菌产生了天然的防湿剂ectoine,达到创纪录的164.6g/L. 代谢工程策略优化了ectoine生物合成,并最大限度地减少了工业应用的副产品.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 微生物生产 微生物生产
背景情况:
- 埃克托因是微生物在极端环境中生存所产生的关键的 osmoprotectant.
- 工业对的需求需要优化和可扩展的生产方法.
研究的目的:
- 在大肠杆菌 (Escherichia coli) 中设计一种高产量的生殖素生产系统.
- 为了增强ectoine生物合成,并最大限度地减少副产品的形成.
主要方法:
- 在大肠杆菌中设计了来自Halomonas venusta的ectABC基因集群.
- 引入了限制速率的酶突变 (EctB E407D) 和阿斯巴托基纳酶突变.
- 实施了分子开关来调节lysA基因表达以进行动态控制.
- 进行了辅助因子工程,以进一步优化.
主要成果:
- 通过酶和通路工程实现了140%的ectoine标位增加.
- 通过使用一种新型基因调节系统,成功控制了氨酸副产品的积累.
- 开发了ECT31菌株,在100升生物反应器中产生164.6g/L的ectoine.
- 使用以大肠杆菌为基础的系统确定了报告中最高的ectoine标位.
结论:
- 提出的代谢工程策略为高效的ectoine生物合成提供了一个新的范式.
- 优化的大肠杆菌菌株可以实现工业相关的生殖素产量.
- 这项工作为具有成本效益的氨基酸衍生物生产铺平了道路.
更多相关视频
16:11Protocols for Implementing an Escherichia coli Based TX-TL Cell-Free Expression System for Synthetic Biology
Published on: September 16, 2013
64.6K
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
9.4K
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
